Roche's antibody cocktail lowers hospitalisation by 70% in Covid-19 patients.

Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of casirivimab and imdevimab met its primary endpoint of reducing...

Peli BioThermal Broadens Portfolio of Dry Ice Shippers.

Peli BioThermal announces expanded dry ice shipper options to support exponential growth in cell and gene therapy shipments worldwide, as well as continued...

BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging.

BioAge Labs announced that it has commenced a Phase 2 clinical trial of BGE-175, a potent oral inhibitor of prostaglandin D2 DP1 signaling with a safety...

CureVac Expands COVID-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant Specification.

CureVac N.V., developing a new class of transformative medicines based on messenger ribonucleic acid, announced plans to expand and further...

RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India.

The RDIF and Virchow Biotech Private Limited announce the agreement to produce in the country up to 200 million doses per year of Sputnik V...

CanSino's Covid-19 vaccine receives approval in Hungary for emergency use.

The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics Covid-19....